Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 218771
Company: ALMAJECT
Company: ALMAJECT
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TERIPARATIDE | TERIPARATIDE | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription | AP | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/04/2024 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218771s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/218771Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/218771Orig1s000TOC.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 01/23/2025 | SUPPL-1 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218771Orig1s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218771Orig1s001ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218771Orig1s001ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 01/23/2025 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218771Orig1s001lbl.pdf | |
| 01/23/2025 | SUPPL-1 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218771Orig1s001lbl.pdf | |
| 06/04/2024 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/218771s000lbl.pdf |
TERIPARATIDE
SOLUTION;SUBCUTANEOUS; 0.56MG/2.24ML (0.25MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| FORTEO | TERIPARATIDE | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription | Yes | AP | 021318 | LILLY |
| TERIPARATIDE | TERIPARATIDE | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription | Yes | AP | 218771 | ALMAJECT |
| TERIPARATIDE | TERIPARATIDE | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription | No | AP | 213641 | AMPHASTAR PHARMS INC |
| TERIPARATIDE | TERIPARATIDE | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription | No | AP | 211097 | APOTEX |
| TERIPARATIDE | TERIPARATIDE | 0.56MG/2.24ML (0.25MG/ML) | SOLUTION;SUBCUTANEOUS | Prescription | No | AP | 208569 | TEVA PHARMS USA |